Addressing the Gap: Accessibility Features for ALS Patients and Their Caregivers in Everyday Technology

A recent study reveals a significant gap in awareness and use of accessibility features in digital devices among ALS patients and caregivers, highlighting opportunities for enhanced support and education to improve quality of life.
A recent study sheds light on a significant oversight in the support system for individuals with Amyotrophic Lateral Sclerosis (ALS) and their caregivers. Despite the fact that over 90% of ALS patients surveyed utilize smartphones, tablets, or computers daily, many are unaware of the built-in accessibility features designed to assist them—tools that could substantially improve their quality of life as the disease progresses.
The research, published in the Journal of Clinical Neuroscience, was conducted by experts including Associate Professor Takehisa Hirayama and Professor Osamu Kano from Toho University. The study highlights that ALS progressively damages motor functions, making routine communication and digital interaction increasingly challenging. Modern devices commonly incorporate features such as voice control, screen readers, and adaptive touch settings—collectively called accessibility functions—to support users with physical limitations. However, findings indicate that awareness and utilization of these features are remarkably low, especially among older adults. Many participants had never activated these settings, and some were unaware they existed at all.
Interestingly, individuals in the early stages of ALS often deal with these technology challenges independently. Because they are still relatively capable, formal assistance is rarely offered, leading to missed opportunities for early adaptation. While many patients remain optimistic about using information and communication technology (ICT) to maintain autonomy, some find reliance on these tools emotionally taxing. For instance, using voice commands or assistive typing can serve as a painful reminder of their declining abilities, sometimes discouraging use altogether.
A concerning discovery from the study is the low awareness of public support services, such as ICT training centers for people with disabilities. Despite their availability in Japan, most respondents were unaware of these resources. This highlights a crucial need for better outreach and education to ensure patients and caregivers can access necessary support.
Overall, the study emphasizes that the potential of technology to empower ALS patients remains largely unrealized due to gaps in awareness and support. As our society becomes increasingly digital, ensuring that vulnerable populations can benefit from these innovations is essential—not only for improving individual quality of life but also for promoting equity and human dignity.
Source: https://medicalxpress.com/news/2025-07-unmet-potential-als-patients-caregivers.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
How Colonic Inflammation Links Obesity to β-Cell Growth and Diabetes Development
New research reveals that colon inflammation triggers a liver-pancreas pathway promoting β-cell proliferation, offering insights into obesity-related diabetes development. This discovery highlights potential therapeutic targets for diabetes prevention.
Innovative Technology Identifies Breast Cancer Relapses up to Five Years Early
A novel blood test developed by Altum Sequencing can predict breast cancer relapse up to five years in advance, revolutionizing post-treatment monitoring and early intervention strategies.
Bone Metastases Promote Immature Immune Cells That Hamper Immunotherapy Effectiveness
New research reveals how bone metastases reprogram immune cells into an immature state that suppresses immune responses and hinders effective immunotherapy. Discover how targeting these processes offers hope for improved cancer treatments.
Genomic Score as a Predictor for Progression in Multiple Myeloma Patients
A new genomic scoring system developed by researchers helps predict the progression of precancerous conditions to active multiple myeloma, paving the way for personalized early interventions.



